Moxiclear Spot On Large Cat
NORBROOK LABS
Moxiclear Spot On Large Cat from NORBROOK LABS is supplied as a spot-on solution.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
UK Public Assessment Report: UKPAR (PDF)
Post-Authorisation Assessment Report: PAAR (PDF)
Active Ingredient(s)
Imidacloprid, Moxidectin
Pack & Presentation
Form: Spot-on solution · Pack size: PK 4
Suitable Species
Cats
Indications
For cats suffering from, or at risk from, mixed parasitic infections: • For the treatment and prevention of flea infestation (Ctenocephalides felis), • the treatment of ear mite infestation (Otodectes cynotis), • the treatment of notoedric mange (Notoedres cati), • the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis), • the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara cati and Ancylostoma tubaeforme). The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Storage & Shelf Life
Do not store above 25°C. Store in the original package in order to protect from light and moisture.
Owner Handling & Safety
Avoid contact with skin, eyes or mouth. Do not eat, drink or smoke during application. Wash hands thoroughly after use.
Contraindications & Warnings
Do not use in kittens under 9 weeks of age. Do not use in cases of hypersensitivity to the active substances or to any of the excipients. For ferrets: Do not use Moxiclear for large cats (0.8 ml) or Moxiclear for dogs (any size).
Use in Pregnancy & Lactation
The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Laboratory studies with either imidacloprid or moxidectin in rats and rabbits have not produced any evidence of teratogenic, foetotoxic or maternotoxic effects.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: Norbrook Laboratories Limited, Station Works, Camlough Road, Newry, Co. Down, BT35 6JP Northern Ireland
- MA number: Vm 02000/4436
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
